Healthcare
·
Diagnostics & Research
The sequencing specialist slipped 0.8% for the week, but a 29.5% 12-week advance, positive Market Dynamics and an active Trend Signal keep the weekly profile constructive. Confirmation is not complete, with volume only 1.1x the 13-week norm
Healthcare
·
Healthcare Plans
UNH added 2.3% for the week and is only 1.8% below its 52-week high, with the Trend Signal active for a fourth week. The caution is participation: volume sat at 0.9x the 13-week average while the Healthcare Plans group rose far faster.
Healthcare
·
Healthcare Plans
Humana closed at $379.20, within 0.1% of its 52-week high, as Healthcare Plans remain one of the strongest groups in US Healthcare. The advance is powerful, but the latest week came on only 0.7x normal volume.
Healthcare
·
Medical Instruments & Supplies
West Pharmaceutical Services added 4.6% for the week and sits just 2.4% below its 52-week high, but participation remains ordinary and Market Dynamics has cooled from earlier June readings.
Healthcare
·
Biotechnology
RVMD added 3.1% in the latest week and remains close to its 52-week high, but participation was below average and Relative Strength has cooled over four weeks.
Healthcare
·
Healthcare Plans
Centene added 4.6% for the week and remains in an active seven-week Trend Signal, but participation is only average as the stock trades above both Fair Value and its weekly Trend Line.